-
Nillessen claims shock European 1,500m gold
-
Lala, now a hurricane, dumps heavy rain on Hawaii
-
Taylor scores two tries in winning debut as New Zealand captain
-
American Kate Douglass reclaims 50m freestyle world record
-
England defender Spence leaves Spurs for Inter Milan
-
Kit confusion disrupts Newcastle friendly against Leverkusen
-
Moore double leads Spurs to 3-0 friendly win over Hoffenheim
-
Marchand wins first Euros gold as Liebmann breaks 1500m free world record
-
Man Utd beaten by former boss Amorim's AC Milan in friendly finale
-
Zambia's vote marred by intimidation, counting pause: observers
-
Villagers evacuate as Belgium battles record wildfire
-
Marchand wins 200m butterfly for first Euros gold
-
Despite booming economy, young Moroccans still dream of Europe
-
Fernandez booed by Chelsea fans in friendly win over Sociedad
-
South Korea president proposes talks with North to formally end Korean War
-
Fans line Welsh streets as Bonnie Tyler body's returns for funeral
-
Residents evacuate as Belgium wildfire scorches 1,600 hectares
-
Tropical Storm Lala lashes Hawaii with heavy rain
-
easyJet strike sees 100 French flights cancelled
-
Lebanon reports 11 dead in strikes that Israel says targeted Hezbollah
-
Monica Bellucci and Florin Serban win at Locarno Film Festival
-
Crystal Palace sign Israel winger Khalaili
-
India's Padikkal hits unbeaten century in first Sri Lanka Test
-
Rescuers search for survivors as Indonesian quake death toll rises to 47
-
Liechtenstein places gender equality on its throne
-
Taliban govt supporters dance, take selfies in Kabul celebrations
-
Street rallies held as Taliban govt marks five years ruling Afghanistan
-
UK PM urges 'reflection' after Cambridge professor's death
-
World Cup winner Ferran Torres signs for PSG from Barcelona
-
Rescuers search for survivors as Indonesian quake death toll rises to 40
-
Monsoon rains submerge villages, fields in Myanmar
-
Earthquake rocks Spain's tourist jewel Granada
-
India's Padikkal, Rahul hit half-centuries in Sri Lanka Test
-
Perez, Fiorini set world records in winning Euro race walk golds
-
UK-based Afghan writer pleads for country's 'abandoned' women
-
Lebanon says 9 dead in strikes as Israel says targeted Hezbollah
-
Werro edges Hodgkinson in boost for world record-seeking 800m rivalry
-
World Cup winner Ferran Torres signs for Paris Saint-Germain
-
Mehidy claims Smith as Bangladesh sense historic upset in Australia
-
Disney reveals 'X-Men' cast, slate of sequels at D23 fan event
-
Indonesia rescuers search for survivors as quake death toll rises to 38
-
Star Cameroon goalkeeper Bihina faces Malawi's prolific Chawinga sisters in WAFCON final
-
Japan coach Jones says team should not get despondent after heavy loss
-
Mehidy claims Smith to keep Bangladesh on top in Australia Test
-
Flags, music as Taliban authorities mark five years ruling Afghanistan
-
Iran fires back at Trump's threat to declare Hormuz a US territory
-
'Like we were on a trampoline': Indonesia quake kills 20, thousands flee
-
No monkey business: India 'whisperers' guard world championships
-
Australia run riot to crush Japan 56-17 in Townsville
-
Steady India 101-1 at lunch in first Sri Lanka Test
US authorizes first condom for use in anal sex
The US Food and Drug Administration (FDA) on Wednesday authorized the first condom for use during anal intercourse, in what was hailed as a victory for sexual health by experts.
Although people already use condoms for anal sex -- as is recommended by health agencies including the Centers for Disease Control and Prevention (CDC) -- regulators across the world had only previously allowed companies to officially market their products as "safe and effective" for vaginal use.
Sexual health advocates considered this an unmet public health need since unprotected anal intercourse carries the greatest risk of HIV transmission via sexual exposure, with one study finding that 69 percent of men who have sex with men would use condoms more frequently if they were FDA-indicated.
Wednesday's authorization of Global Protection Corp's One Male Condom follows a clinical trial involving more than 500 people, carried out by Emory University.
"The FDA's authorization of a condom that is specifically indicated, evaluated and labeled for anal intercourse may improve the likelihood of condom use during anal intercourse," said agency scientist Courtney Lias in a statement.
The condom is also indicated to prevent sexually transmitted infections -- and as a contraceptive -- during vaginal sex.
"We want people to have lots of sex -- but we also want them to be empowered and informed," said Davin Wedel, president of Global Protection Corp, which makes the condom brand that is available in 54 sizes, and incorporates a paper template to help each user find the right size.
The clinical trial involved 252 men who have sex with men and 252 men who have sex with women, aged between 18 and 54.
The FDA had said it would accept a five percent failure rate, which previous trials had failed to accomplish. The limit was easily surpassed in the new study, with the failure rate 0.68 percent for anal and 1.89 percent for vaginal intercourse.
The researchers behind the study, which was published in The Lancet's eClinicalMedicine, said one of the reasons the trial succeeded where others failed in the past was likely due to the provision of lubricant and inclusion of instructions on how to use the product.
Lubricant reduces friction, which in turn causes condom failure from slippage and breakage.
Another reason could be that participants were asked to keep mobile phone-based daily diaries, whereas past trials had asked volunteers to recall failure events up to several months later.
Monica Gandhi, an infectious disease doctor and medical director of an HIV clinic in San Francisco, welcomed the finding.
"The important thing about condoms is they don't just prevent HIV, but they prevent gonorrhea, chlamydia and syphilis," she told AFP, adding it was surprising that such an authorization had taken so long to achieve.
In its statement, the FDA said the green light could pave the way for more makers to apply for similar authorization if they show equivalent results.
P.Mathewson--AMWN